Following the High Court’s ruling that Myriad’s claims for isolated DNA relating to BRCA1 were not patentable subject matter, IP Australia has released a “consultation” on how it proposes to treat patent applications claiming genetic material.
The Productivity Commission has released an issues paper for its inquiry into Intellectual Property Arrangements.
A closer look at the High Court’s ruling in D’Arcy v Myriad
High Court allows D’Arcy’s appeal against patentability of isolated gene sequences for BRCA1
The Full Federal Court has held that the (+) enantiomer of citalopram is itself a pharmaceutical substance per se and so eligible for term extension
The High Court has dismissed Astrazeneca’s appeal against the finding that its rosuvastatin patent was obvious.
Nicholas J stays dissolution of interlocutory injunction pending Otsuka’s appeal from invalidity of aripiprazole patent judgment. Commonwealth gets security for undertaking as to damages.
Minister announce Productivity Commission to review Australia’s IP laws
IP Australia issues consultation paper on ACIP’s report into the innovation patent system
WIPO has published 2 studies on inventive step and sufficiency of disclosure in patent laws.